Report: More than half of the world's population will be overweight/obese by 2035

Published Date: 08 Mar 2023

The World Health Organization's 2023 Atlas predicts that 51% of the world's population, or more than 4 billion people, will be overweight or obese within the next 12 years.

Read Full News

Latest News

Prior Bariatric Surgery Lowers Postop Risk Over GLP-1s

Another Pregnancy Can Worsen Insulin Sensitivity Over Time

In parous women, an additional pregnancy is linked to a selective decline in whole-body insulin sensitivity over 10 years, with no clear changes in beta-cell function or blood glucose levels.

Tirzepatide Effective Despite Weight-Inducing Meds

Tirzepatide is linked to significant weight loss in adults with overweight or obesity who are taking weight-inducing medications, suggesting benefits even when these therapies are continued.

US FDA Clarifies Policies on Compounding Of GLP-1 Medicines

The U.S. Food and Drug Administration on Wednesday clarified its policies on compounded versions of ⁠popular GLP-1 drugs, signaling tighter limits on their production as...

Analysis Links RAI Therapy to Breast Cancer Risk

Clinicians may want to discuss radioactive iodine therapy’s potential for increasing breast cancer risk with patients undergoing hyperthyroidism treatment, researchers say.

Immunovant's Treatment for Eye Disease Fails in Late-stage Trials

Immunovant said on Thursday that its therapy failed to reduce eye bulging ⁠when tested in patients with moderate-to-severe thyroid eye disease in two late-stage...

Todays Updates

Maternal BMI and Birth Length Tied to Dermatitis Risk

A higher maternal prepregnancy BMI and greater birth length are associated with an elevated risk for atopic dermatitis in offspring by 3 years of age, new research shows.

Enteritis Linked to Increased Long-Term Risk for IBS

Infectious enteritis is associated with an increased long-term risk of developing irritable bowel syndrome, functional dyspepsia, and elevated healthcare use.

Todays Updates

Maternal BMI and Birth Length Tied to Dermatitis Risk

A higher maternal prepregnancy BMI and greater birth length are associated with an elevated risk for atopic dermatitis in offspring by 3 years of age, new research shows.

Enteritis Linked to Increased Long-Term Risk for IBS

Infectious enteritis is associated with an increased long-term risk of developing irritable bowel syndrome, functional dyspepsia, and elevated healthcare use.

Latest News

In parous women, an additional pregnancy is linked to a selective decline in whole-body insulin sensitivity over 10 years, with no clear changes in beta-cell function or blood glucose levels.

Tirzepatide is linked to significant weight loss in adults with overweight or obesity who are taking weight-inducing medications, suggesting benefits even when these therapies are continued.

The U.S. Food and Drug Administration on Wednesday clarified its policies on compounded versions of ⁠popular GLP-1 drugs, signaling tighter limits on their production as...

Clinicians may want to discuss radioactive iodine therapy’s potential for increasing breast cancer risk with patients undergoing hyperthyroidism treatment, researchers say.

Immunovant said on Thursday that its therapy failed to reduce eye bulging ⁠when tested in patients with moderate-to-severe thyroid eye disease in two late-stage...

News All Time

EMA Clears New First-Line Options for Advanced Cancers

European regulators have backed RET inhibitor and PD-1 regimens, expanding first line options in advanced lung, thyroid, and esophageal cancers.

NICE Introduces Endometriosis Fertility Pathway

An updated NICE guideline sets out a dedicated pathway for endometriosis within wider fertility guidance.

Weight Loss May Cut Cancer Risk in Adults With Obesity

Nonsurgical weight loss is associated with reduced incident risks for both obesity-related and other cancers in adults with obesity.

Medtronic Gets US FDA Nod to Use Surgical System in Cranial, ENT Surgeries

Medtronic said on Friday the U.S. Food and Drug Administration has cleared its surgical system ⁠for cranial and ear, nose and throat procedures, expanding the platform...

EU Reaffirms Rejection of Rare Sleep Disorder Drug

The sleep drug failed to gain approval for nighttime disruptions in children with a rare genetic disorder affecting circadian rhythm patterns.

Experts Question Evidence for New Testosterone Advice

New federal dietary guidance includes advice on boosting testosterone levels, which clinicians say is only partially rooted in evidence.

Once- or Twice-Yearly Injection for Weight Loss?

Phase 1 data suggest that WVE-007, an investigational siRNA drug given by injection, leads to reductions in visceral fat, waist circumference, and body weight.

Do ESAs for Anemia Raise Cancer Risk in Dialysis Patients?

High doses of erythropoiesis-stimulating agents were associated with an increased risk for cancer in patients on dialysis, but the real risk attributed to these medications remains unclear.

Ontario Government Proposes New Integrated EMR System

As Ontario proposes a new connected primary care medical record system, healthcare advocates are hoping to avoid the perils of previous attempts.

FDA Approves First Once-Weekly Insulin for Type 2 Diabetes

Novo Nordisk’s icodec-abae is now approved in the US for type 2 diabetes only, after a prior rejection partly due to concerns about hypoglycemia in type 1 diabetes.

US FDA Approves Novo's Insulin Injection for Type 2 Diabetes

The U.S. Food and Drug ⁠Administration has approved Novo Nordisk's insulin injection, ⁠Awiqli, to control blood sugar levels ⁠in adults ‌living with type 2 diabetes, the...

Dad’s Nicotine Use May Shape Kids’ Metabolic Health

Paternal nicotine use alters metabolism in offspring, and those changes are sex-specific, a study in mice shows.

Dementia Risk May Triple With Type 1 Diabetes

The risk for dementia is significantly higher in people with diabetes, with the greatest risk among those with type 1 disease, new research shows.

Does Eating the Same Foods Work Best for Weight Loss?

Repeating the same meals and keeping calorie intake steady produces more weight loss than eating a more varied diet among individuals living with overweight or obesity.

Elinzanetant Reduces Vasomotor Symptoms in Breast Cancer

Elinzanetant reduces the severity and frequency of hot flushes and night sweats among women with breast cancer regardless of type of endocrine treatment used.

Germany Renews Push for Sugar Tax & Energy Drinks Ban for Kids

A German push to tax sugary drinks and ban energy drinks for under-16s will be voted on by the country's assembly of regional states on Friday.

Recommended News For You

When Should Immunocompromised Individuals Receive a COVID Booster?

Data-driven risk stratification guides childhood brain tumor treatment, reducing side effects

Researchers find distinct cell receptors with the potential for new treatments.

Drug-chemo combo increases cancer treatment efficacy

Coffee and tea linked to lower head and neck cancer risk

I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.

Smart exercise planning could boost recovery for people with cancer

Recommended Articles For You

Uncovering the Hidden Picture: Using Ultrasound to Diagnose Breast Cancer 

Precision to Personalization: Expanding Genetic Testing and Counseling in Oncology 

Unlocking the Secrets of Improved Ovarian Cancer Survival Rates 

Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study finds 81% of cancer cures touted by TikTok videos are fake

2.

Telemedicine Not Reaching Rural Psychiatric Patients

3.

Parents, teachers at Missouri school want answers after string of cancer diagnoses

4.

A study outlines the need for policies that enhance cancer patients' autonomy and information.

5.

'It's rare and it's scary.' Dark spot on your fingernail could mean cancer

1.

The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide

2.

Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care

3.

Understanding Mantle Cell Lymphoma Prognosis.

4.

Predicting Incidental Prostate Cancer in BPH Surgery Patients

5.

Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis

2.

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

3.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

4.

Updates on Standard V/S High Risk Myeloma Treatment

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot